Duke University
This article was originally published in The Tan Sheet
Executive Summary
Resolution of clinical trial enrollment suspension announced May 14. HHS' Office for Protection from Research Risks informed the school its "corrective plans" are "satisfactory" to resolve problems with administrative procedures employed in the review of research proposals ("The Tan Sheet" May 17, In Brief). The National Institute of Mental Health/NIH Center for Complementary & Alternative Medicine study of St. John's wort was affected by the temporary suspension
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning